Shattuck Labs (STTK) Change in Accured Expenses (2019 - 2026)
Shattuck Labs' (STTK) quarterly Change in Accured Expenses came in at -$2.0 million in Q1 2026, down 173.04% year-on-year from $2.7 million in Q1 2025, and down 321.66% on a QoQ basis from $882000.0 in Q4 2025.
Shattuck Labs (STTK) Change in Accured Expenses (2019 - 2026) Analysis & Trends
Shattuck Labs (STTK) has 8 years of Change in Accured Expenses data on file, last reported at -$2.0 million in Q1 2026.
- On a quarterly basis, Change in Accured Expenses fell 173.04% year-over-year to -$2.0 million in Q1 2026; TTM through Mar 2026 was -$2.7 million, a 25.87% decrease from a year earlier, with the FY2025 full-year figure at -$1.4 million, up 57.19% from the prior year.
- Change in Accured Expenses for Q1 2026 stood at -$2.0 million, down from $882000.0 in the prior quarter.
- Over the last five years, Change in Accured Expenses for STTK reached as high as $4.1 million in Q2 2022 and fell as low as -$7.4 million in Q1 2023.
- Historically, Change in Accured Expenses has averaged -$710764.7 across 5 years, with a median of -$687000.0 in 2025.
- Across the five-year window, Change in Accured Expenses sank 1123.96% in 2023 and jumped 923.12% in 2024, its largest moves.
- Year by year, Change in Accured Expenses stood at $1.9 million in 2022, then plunged by 206.91% to -$2.0 million in 2023, then sank by 45.81% to -$3.0 million in 2024, then jumped by 129.64% to $882000.0 in 2025, then plunged by 321.66% to -$2.0 million in 2026.
- Per Business Quant data, the three most recent Change in Accured Expenses figures were -$2.0 million in Q1 2026, $882000.0 in Q4 2025, and -$687000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 1.13 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 931,000.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | -16.82 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 23.10 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 107.70 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -16.74 Mn |
| 10 | Shattuck Labs | 831.66 Mn | 831.66 Mn | - | -1.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.96 Mn |
| Mar 31, 2026 | -1.96 Mn |
| Dec 31, 2025 | 882,000.00 |
| Dec 31, 2025 | 882,000.00 |
| Sep 30, 2025 | -687,000.00 |
| Sep 30, 2025 | -687,000.00 |
| Jun 30, 2025 | -921,000.00 |
| Jun 30, 2025 | -921,000.00 |
| Mar 31, 2025 | -716,000.00 |
| Mar 31, 2025 | -716,000.00 |
| Dec 31, 2024 | -2.98 Mn |
| Dec 31, 2024 | -2.98 Mn |
| Sep 30, 2024 | -76,000.00 |
| Sep 30, 2024 | -76,000.00 |
| Jun 30, 2024 | 1.64 Mn |
| Jun 30, 2024 | 1.64 Mn |
| Mar 31, 2024 | -1.95 Mn |
| Mar 31, 2024 | -1.95 Mn |
| Dec 31, 2023 | -2.04 Mn |
| Dec 31, 2023 | -2.04 Mn |